Liquid Biopsy for Lung Cancer: A Complete Guide
- Following a liquid biopsy procedure, patients can typically resume their normal activities without limitations.
- While liquid biopsies exhibit high accuracy in confirming positive results, negative results may necessitate further examination. Doctors might order a tissue biopsy to confirm the findings.
- hirsch, MD, PhD, executive director of the Center for Thoracic Oncology at the Mount Sinai Tisch Cancer Institute, noted the potential limitations.
Liquid biopsies are revolutionizing lung cancer treatment, providing a non-invasive method for monitoring the disease. This complete guide dives into how liquid biopsies work, explaining the process and timelines, typically returning results in 1-2 weeks. Discover the benefits of this innovative approach, including its use in monitoring treatment effectiveness and detecting early signs of resistance. While highly accurate in confirming positive results, doctors may use a tissue biopsy to validate negative findings. News Directory 3 keeps you informed on the latest breakthroughs. Explore the future of lung cancer care, and uncover how liquid biopsies are poised to play an even bigger role in patient care. Discover what’s next in the field of cancer treatment.
liquid Biopsies Show Promise in Lung cancer Treatment
updated june 05, 2025
Following a liquid biopsy procedure, patients can typically resume their normal activities without limitations. The analysis of the sample generally requires one to two weeks. afterward, a health care provider will explain the results and discuss what they mean for the patient’s care.
While liquid biopsies exhibit high accuracy in confirming positive results, negative results may necessitate further examination. Doctors might order a tissue biopsy to confirm the findings.
Fred R. hirsch, MD, PhD, executive director of the Center for Thoracic Oncology at the Mount Sinai Tisch Cancer Institute, noted the potential limitations. Hirsch said the amount of DNA in the blood can vary based on tumor size and stage. He added that sometimes there isn’t enough DNA for reliable examination, and discrepancies can occur between molecular findings in the blood and in the tumor itself.
“I see a role for liquid biopsy in the treatment decisions for individual patients,” Hirsch said.
Hirsch also anticipates liquid biopsies playing a larger role in the future of lung cancer treatment. This includes monitoring how well a treatment is working and detecting early signs of resistance to molecular therapy or immunotherapy.According to Hirsch, liquid biopsies could identify increasing levels of abnormal tumor DNA in the bloodstream, possibly indicating tumor progression earlier than a CT scan.
What’s next
Scientists are rapidly advancing liquid biopsy technologies, aiming for more sensitive and reliable results in the ongoing fight against lung cancer.